Anastomosis Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented by Usage, Type, Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Other Applications), and Geography

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The anastomosis devices market was anticipated to register a CAGR of 7.0% during the forecast period. The major factors driving the growth of the market are the increase in the number of cardiac and gastrointestinal surgeries globally. This resulted in increased use during the procedures. Higher demand for surgeries, like CABG (Coronary Artery Bypass Grafting), Partial colectomy, and other thoracic surgeries, due to the global prevalence of various coronary heart diseases and the rise in the geriatric population. For instance, according to WHO, 17.9 million of the population die every year. Additionally, cardiac diseases, like coronary heart disease, hypertension, and stroke, were ranked as the prominent causes of deaths worldwide. Furthermore, the increased adoption of endoscopic surgeries, favorable reimbursement policies, and technological advancements are expected to fuel the growth of the market. 

Scope of the Report

An anastomosis is a surgical procedure that involves connecting two structures and is performed after resection of an organ to connect the remaining sections. It is a critical step in surgery and has a high risk for complications which requires highly efficient and advanced devices to perform. As per the scope of the report, various types of anastomotic devices were discussed in detail.

By Usage
Disposable
Reusable
By Type
Surgical Staplers
Surgical Sutures
Surgical Sealants and Adhesives
Other Types
By Application
Cardiovascular Surgery
Gastrointestinal Surgery
Others
Geography
North America
United states
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Cardiovascular Surgery Segment is Expected to Hold the Largest Market Share in the Anastomosis Devices Market

Cardiovascular surgeries, by application, are expected to witness the largest market share in the anastomosis devices market during the forecast period. This dominance is due to the increased use of various devices, such as the surgical staplers, and surgical sealants and adhesives in various cardiac surgeries. The increased demand for these devices in aortic surgery, arrhythmia surgery, myectomy, and CABG procedures can be attributed to their ability to minimize the risk of complications and reduce anastomotic leaks. Furthermore, the increasing number of cardiac diseases demands technologically advanced products, propelling the growth of the segment. On the other hand, the gastrointestinal surgeries segment is anticipated to witness the highest CAGR over the course of the forecast period. The lucrative growth of the segment can be due to the rising number of gastrointestinal cancers across the world. As per the American Cancer Society’s estimates for the year 2020, stomach cancer affects about 27,600 and causing 11,010 deaths in the United States. Also, the report states that surgery like endoscopic resection, partial gastrectomy, etc., can only offer a realistic chance for cure of this type of cancer. Thus, the adoption of surgery as an essential part of the treatment for many different stages of stomach cancer is expected to boost the growth of the segment.

CVD Deaths in The US by Year in Millions.png

North America Dominates the Market and Expected to do Same in the Forecast Period.

North America is expected to dominate the overall anastomosis devices market throughout the forecast period. The major factors attributing to the growth are the increase in the global prevalence of multiple cardiovascular indications, like CAD, strokes, and gastric cancers, like adenocarcinoma, lymphoma, etc., Thus, a rise in surgical procedures increased the demand for these surgical devices. As per the American Heart Association, in 2018, nearly 92.1 million individuals in the US suffered from cardiovascular diseases leading to 3244 heart transplantations. Thus, the higher demand for these devices during surgical procedures drives the market in the region. Deskbound lifestyle, increasing geriatric population with chronic diseases in the region contribute to its outstanding share of revenue propelling the global anastomosis devices market.

Surgical Staplers

Competitive Landscape

The anastomosis market is moderately competitive and consists of several major players. Few of the key players are developing novel products and technologies to compete with the products trending in the market. For instance, in September 2019, Ethicon launched its ECHELON CIRCULAR Powered Circular Stapler which utilizes an innovative Gripping Surface and 3D Stapling Technologies. The stapler is designed to reduce leaks without compromising perfusion. Such innovative launches are expected to impel the global anastomosis market growth throughout the forecast period. Some of the companies which are currently dominating the market are Medtronic PLC, LivaNova PLC, Getinge AB, Johnson & Johnson (Ethicon US, LLC), and Baxter International Inc. (Synovis Micro Companies Alliance Inc.)

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Number of Surgical Procedures like Colectomy, CABG and Others

      2. 4.2.2 Availability of Technologically Advanced Products and Reimbursement Policies

    3. 4.3 Market Restraints

      1. 4.3.1 Adoption of Minimally Invasive Procedures like Percutaneous Coronary Interventions

      2. 4.3.2 Highly Expensive Treatments and Lack of Advanced Healthcare Infrastructure

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Usage

      1. 5.1.1 Disposable

      2. 5.1.2 Reusable

    2. 5.2 By Type

      1. 5.2.1 Surgical Staplers

      2. 5.2.2 Surgical Sutures

      3. 5.2.3 Surgical Sealants and Adhesives

      4. 5.2.4 Other Types

    3. 5.3 By Application

      1. 5.3.1 Cardiovascular Surgery

      2. 5.3.2 Gastrointestinal Surgery

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United states

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Baxter International Inc. (Synovis Micro Companies Alliance)

      2. 6.1.2 Medtronic PLC

      3. 6.1.3 LivaNova PLC

      4. 6.1.4 Getinge AB

      5. 6.1.5 Johnson & Johnson (Ethicon US LLC.)

      6. 6.1.6 Meril Life Sciences Pvt. Ltd

      7. 6.1.7 Becton, Dickinson and Company

      8. 6.1.8 Intuitive Surgical Inc.

      9. 6.1.9 Boston Scientific Corporation

      10. 6.1.10 B. Braun Melsungen AG

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Anastomosis Devices Market market is studied from 2018 - 2026.

The Anastomosis Devices Market is growing at a CAGR of 7% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Baxter International Inc. (Synovis Micro Companies Alliance, Inc.), Medtronic Plc, LivaNova PLC, Getinge AB, Johnson & Johnson (Ethicon US, LLC.) are the major companies operating in Anastomosis Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!